Pre-clinical models of infectious diseases: establishment of small animal models for screening mcms for the 2019 novel coronavirus (SARS-COV-2)
Ended Awarded Last action
- Contract number
- 75N93020F00001
- Awardee
-
Utah State University UEI SPE2YDWHDYU4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,006,666
Award facts
- Contract value 79% obligated
- $2,542,966.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 8 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Logan, UT 84322, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$98,591 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $479,650 | |
| Exercise an Option | $703,656 | |
| Original award | $921,951 |
About this award
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $2.5 million delivery order to Utah State University, doing business as USU, to establish small animal models for screening medical countermeasures against SARS-CoV-2, the virus that causes COVID-19. This delivery order was issued against NIAID's Preclinical Models of Infectious Diseases master IDIQ contract, valued between $2.5 billion to $5 billion over its 2017-2024 period of performance, which aims to provide animal models, testing services, and research support. Work will be conducted at USU's facilities in Logan, Utah through January 2023. As the funding agency, NIAID conducts and supports research on infectious and immune-mediated diseases to enhance control of global infectious disease threats including COVID-19.
Quick answers
Who was awarded contract 75N93020F00001?
75N93020F00001 was awarded to Utah State University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on March 23, 2020.
How much is contract 75N93020F00001 worth?
The government has obligated $2,006,666 on 75N93020F00001. Its current value, with exercised options, is $2,542,967.
Is contract 75N93020F00001 an order under another contract?
Yes. 75N93020F00001 is a delivery order under HHSN272201700041I, an indefinite delivery contract, on NIAID Preclinical Models of Infectious Diseases 2017-2024.
Was contract 75N93020F00001 competed?
The extent of competition for 75N93020F00001 was full and open competition. The government received 8 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award